zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2022-19-1-03zdor-2171Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESОрганизация медицинской помощи пациентам онкологического профиля в условиях пандемии COVID-19Management of cancer patients during the COVID-19 pandemichttps://orcid.org/0000-0001-6027-0078ВолчекВ. С.VolchekV. S.

Волчек Владислав Станиславович, врач-интерн, хирург-онколог

Гомель

Vladislav S. Volchek, medical intern, surgical oncologist

Gomel

volvst@yandex.ruГомельский областной клинический онкологический диспансерGomel Regional Clinical Oncological Dispensary2022300320221912126Copyright © Волчек В.С., 20222022Волчек В.С.Volchek V.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/2171

В статье приведен обзор данных зарубежной литературы, включающий ряд аспектов, отражающих рекомендации по организации медицинской помощи пациентам онкологического профиля в условиях пандемии COVID-19. Автор акцентирует внимание на том, что пандемия стала серьезным вызовом для системы оказания медицинской помощи не только в Республике Беларусь, но и продемонстрировала ряд проблем в организации здравоохранения в большинстве стран мира. В частности, пандемия привела к ухудшению ситуации с доступностью и качеством медицинской помощи, оказываемой пациентам онкологического профиля, а в периодических изданиях часто появляются сообщения о высоком риске тяжелых осложнений у данной группы населения при развитии COVID-19.

This article provides a review of foreign literature data including a number of aspects that cover guidelines on cancer patient management during the COVID-19 pandemic. The author focuses on the fact that the pandemic has become a serious challenge for the health system not only in the Republic of Belarus, but also has demonstrated a number of problems in the organization of healthcare in most countries of the world. In particular, the pandemic has led to a deteriorated situation with the availability and quality of medical care provided to cancer patients, and periodicals often report a high risk of severe complications in this population group during the spread of COVID-19.

коронавируспандемияонкологияCOVID-19вакцинацияонкоскринингхимиотерапиялучевая терапия.coronaviruspandemiconcologyCOVID-19vaccinationcancer screeningchemotherapyradiation therapyReferencesWorld Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. [date of access 2021 February 12]. Available from: http://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. [date of access 2021 February 12]. Available from: http://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020Yu J, Ouyang W, Chua M, Xie C. SARS-CoV-2 Transmission in patients with cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncology. 2020;6(7):1108-1110. https://doi.org/10.1001/jamaoncol.2020.0980Yu J, Ouyang W, Chua M, Xie C. SARS-CoV-2 Transmission in patients with cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncology. 2020;6(7):1108-1110. https://doi.org/10.1001/jamaoncol.2020.0980Lewis M. Between Scylla and Charybdis — Oncologic Decision Making in the Time of Covid-19. The New England Journal of Medicine. 2020;382:2285-2287. https://doi.org/10.1056/nejmp2006588Lewis M. Between Scylla and Charybdis — Oncologic Decision Making in the Time of Covid-19. The New England Journal of Medicine. 2020;382:2285-2287. https://doi.org/10.1056/nejmp2006588Cannistra S, Haffty B, Ballman K. Challenges Faced by Medical Journals During the COVID-19 Pandemic. Journal of Clinical Oncology, 2020;38(19):2206. https://doi.org/10.1200/jco.20.00858Cannistra S, Haffty B, Ballman K. Challenges Faced by Medical Journals During the COVID-19 Pandemic. Journal of Clinical Oncology, 2020;38(19):2206. https://doi.org/10.1200/jco.20.00858London J, Fazio-Eynullayeva E, Palchuk M, et al. Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters. JCO Clinical Cancer Informatics. 2020;4:657-665. (Published online July 27, 2020). https://doi.org/10.1200/cci.20.00068London J, Fazio-Eynullayeva E, Palchuk M, et al. Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters. JCO Clinical Cancer Informatics. 2020;4:657-665. (Published online July 27, 2020). https://doi.org/10.1200/cci.20.00068ASCO Special report: Guide to cancer care delivery during the COVID-19 pandemic. [date of access 2021 February 12]. Available from: http://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdfASCO Special report: Guide to cancer care delivery during the COVID-19 pandemic. [date of access 2021 February 12]. Available from: http://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdfCinar P, Kubal T, Freifeld A, et al. Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe. Journal of the National Comprehensive Cancer Network. 2020;18(5):504-509. https://doi.org/10.6004/jnccn.2020.7572Cinar P, Kubal T, Freifeld A, et al. Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe. Journal of the National Comprehensive Cancer Network. 2020;18(5):504-509. https://doi.org/10.6004/jnccn.2020.7572Mazzone P, Gould M, Arenberg D, et al. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest, 2020;158(1):406-415. https://doi.org/10.1016/j.chest.2020.04.020Mazzone P, Gould M, Arenberg D, et al. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest, 2020;158(1):406-415. https://doi.org/10.1016/j.chest.2020.04.020Ciavattini A, Delli Carpini G, Giannella L, et al. Expert consensus from the Italian Society for Colposcopy and Cervico-Vaginal Pathology (SICPCV) for colposcopy and outpatient surgery of the lower genital tract during the COVID-19 pandemic. International Journal of Gynecology & Obstetrics. 2020;149(3):269-272. https://doi.org/10.1002/ijgo.13158Ciavattini A, Delli Carpini G, Giannella L, et al. Expert consensus from the Italian Society for Colposcopy and Cervico-Vaginal Pathology (SICPCV) for colposcopy and outpatient surgery of the lower genital tract during the COVID-19 pandemic. International Journal of Gynecology & Obstetrics. 2020;149(3):269-272. https://doi.org/10.1002/ijgo.13158Ceugnart L, Delaloge S, Balleyguier C, et al. Dépistage et diagnostic du cancer du sein à la fin de période de confinement COVID-19, aspects pratiques et hiérarchisation des priorités [Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies]. Bull Cancer. 2020;107(6):623-628. https://doi.org/10.1016/j.bulcan.2020.04.006Ceugnart L, Delaloge S, Balleyguier C, et al. Dépistage et diagnostic du cancer du sein à la fin de période de confinement COVID-19, aspects pratiques et hiérarchisation des priorités [Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies]. Bull Cancer. 2020;107(6):623-628. https://doi.org/10.1016/j.bulcan.2020.04.006ASCCP interim guidance for timing of diagnostic and treatment procedures for patients with abnormal cervical screening tests. [date of access 2021 February 12]. Available from: http://www.asccp.org/covid-19ASCCP interim guidance for timing of diagnostic and treatment procedures for patients with abnormal cervical screening tests. [date of access 2021 February 12]. Available from: http://www.asccp.org/covid-19McBain R, Cantor J, Jena A, et al. Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic. Journal of General Internal Medicine. 2021;36:1829-1831. https://doi.org/10.1007/s11606-021-06660-5McBain R, Cantor J, Jena A, et al. Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic. Journal of General Internal Medicine. 2021;36:1829-1831. https://doi.org/10.1007/s11606-021-06660-5Bakouny Z, Paciotti M, Schmidt A, et al. Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncology. 2021;7(3):458-460. https://doi.org/10.1001/jamaoncol.2020.7600Bakouny Z, Paciotti M, Schmidt A, et al. Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncology. 2021;7(3):458-460. https://doi.org/10.1001/jamaoncol.2020.7600Chen R, Haynes K, Du S, et al. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. JAMA Oncology. 2021;7(6):878-884. https://doi.org/10.1001/jamaoncol.2021.0884Chen R, Haynes K, Du S, et al. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. JAMA Oncology. 2021;7(6):878-884. https://doi.org/10.1001/jamaoncol.2021.0884Amit M, Tam S, Bader T, et al. Pausing cancer screening during the severe acute respiratory syndrome coronavirus-2 pandemic: Should we revisit the recommendations? European Journal of Cancer. 2020;134:86-89. https://doi.org/10.1016/j.ejca.2020.04.016Amit M, Tam S, Bader T, et al. Pausing cancer screening during the severe acute respiratory syndrome coronavirus-2 pandemic: Should we revisit the recommendations? European Journal of Cancer. 2020;134:86-89. https://doi.org/10.1016/j.ejca.2020.04.016Ricciardiello L, Ferrari C, Cameletti M, et al. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality. Clinical Gastroenterology and Hepatology. 2021;19(7):1410-1417. https://doi.org/10.1016/j.cgh.2020.09.008Ricciardiello L, Ferrari C, Cameletti M, et al. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality. Clinical Gastroenterology and Hepatology. 2021;19(7):1410-1417. https://doi.org/10.1016/j.cgh.2020.09.008Alagoz O, Lowry K, Kurian A, et al. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. Journal of the National Cancer Institute. 2021;113(11):1484-1494. https://doi.org/10.1093/jnci/djab097Alagoz O, Lowry K, Kurian A, et al. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. Journal of the National Cancer Institute. 2021;113(11):1484-1494. https://doi.org/10.1093/jnci/djab097Velazquez A, Hayward J, Gregory B, Dixit N. Trends in Breast Cancer Screening in a Safety-Net Hospital During the COVID-19 Pandemic. JAMA Netw Open. 2021;4(8):e2119929. https://doi.org/10.1001/jamanetworkopen.2021.19929Velazquez A, Hayward J, Gregory B, Dixit N. Trends in Breast Cancer Screening in a Safety-Net Hospital During the COVID-19 Pandemic. JAMA Netw Open. 2021;4(8):e2119929. https://doi.org/10.1001/jamanetworkopen.2021.19929Basu P, Alhomoud S, Taghavi K, et al. Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation. JCO Global Oncology. 2021;7(416). https://doi.org/10.1200/go.21.00033Basu P, Alhomoud S, Taghavi K, et al. Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation. JCO Global Oncology. 2021;7(416). https://doi.org/10.1200/go.21.00033Neal R, Nekhlyudov L, Wheatstone P, Koczwara B. Cancer care during and after the pandemic. BMJ. 2020;370:m2622. https://doi.org/10.1136/bmj.m2622Neal R, Nekhlyudov L, Wheatstone P, Koczwara B. Cancer care during and after the pandemic. BMJ. 2020;370:m2622. https://doi.org/10.1136/bmj.m2622Helsper C, Campbell C, Emery J, et al. Cancer has not gone away: A primary care perspective to support a balanced approach for timely cancer diagnosis during COVID-19. European Journal of Cancer Car. 2020;29(5):e13290. https://doi.org/10.1111/ecc.13290Helsper C, Campbell C, Emery J, et al. Cancer has not gone away: A primary care perspective to support a balanced approach for timely cancer diagnosis during COVID-19. European Journal of Cancer Car. 2020;29(5):e13290. https://doi.org/10.1111/ecc.13290Kregting L, Kaljouw S, de Jonge L, et al. Effects of cancer screening restart strategies after COVID-19 disruption. British Journal of Cancer. 2021;124:1516-1523. https://doi.org/10.1038/s41416-021-01261-9Kregting L, Kaljouw S, de Jonge L, et al. Effects of cancer screening restart strategies after COVID-19 disruption. British Journal of Cancer. 2021;124:1516-1523. https://doi.org/10.1038/s41416-021-01261-9Miglioretti D, Bissell M, Kerlikowske K, et al. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Network Open. 2021;4(3):e211974. https://doi.org/10.1001/jamanetworkopen.2021.1974Miglioretti D, Bissell M, Kerlikowske K, et al. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Network Open. 2021;4(3):e211974. https://doi.org/10.1001/jamanetworkopen.2021.1974Local reactions, systemic reactions, adverse events, and serious adverse events: Moderna COVID-19 Vaccine. Centers for Disease Control and Prevention. [date of access 2021 February 25]. Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.htmlLocal reactions, systemic reactions, adverse events, and serious adverse events: Moderna COVID-19 Vaccine. Centers for Disease Control and Prevention. [date of access 2021 February 25]. Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.htmlLocal reactions, systemic reactions, adverse events, and serious adverse events: Pfizer-BioNTech COVID-19 Vaccine. Centers for Disease Control and Prevention. [date of access 2021 February 25]. Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.htmlLocal reactions, systemic reactions, adverse events, and serious adverse events: Pfizer-BioNTech COVID-19 Vaccine. Centers for Disease Control and Prevention. [date of access 2021 February 25]. Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.htmlRobinson K, Maimone S, Gococo-Benore D, et al. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination. JAMA Oncology. 2021;7(9):13951397. https://doi.org/10.1001/jamaoncol.2021.3127Robinson K, Maimone S, Gococo-Benore D, et al. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination. JAMA Oncology. 2021;7(9):13951397. https://doi.org/10.1001/jamaoncol.2021.3127Adin M, Isufi E, Kulon M, Pucar D. Association of COVID-19 mRNA Vaccine With Ipsilateral Axillary Lymph Node Reactivity on Imaging. JAMA Oncology, 2021;7(8):1241-1242. https://doi.org/10.1001/jamaoncol.2021.1794Adin M, Isufi E, Kulon M, Pucar D. Association of COVID-19 mRNA Vaccine With Ipsilateral Axillary Lymph Node Reactivity on Imaging. JAMA Oncology, 2021;7(8):1241-1242. https://doi.org/10.1001/jamaoncol.2021.1794Becker A, Perez-Johnston R, Chikarmane S, et al. Multidisciplinary Recommendations Regarding PostVaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel. Radiology. 2021;300:E323-327. https://doi.org/10.1148/radiol.2021210436Becker A, Perez-Johnston R, Chikarmane S, et al. Multidisciplinary Recommendations Regarding PostVaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel. Radiology. 2021;300:E323-327. https://doi.org/10.1148/radiol.2021210436Lehman C, D’Alessandro H, Mendoza D, et al. Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties. Journal of the American College of Radiology, 2021;18(6):843-852. https://doi.org/10.1016/j.jacr.2021.03.001Lehman C, D’Alessandro H, Mendoza D, et al. Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties. Journal of the American College of Radiology, 2021;18(6):843-852. https://doi.org/10.1016/j.jacr.2021.03.001

The authors declare that there are no conflicts of interest present.